Oxford Scientists Race Against Time to Develop Bundibugyo Ebola Vaccine as DRC Outbreak Spreads
Researchers at the Oxford Vaccine Group (OVG) are working urgently to develop a vaccine for Bundibugyo Ebolavirus amid an outbreak in Africa. “In response to the current Bundibugyo Ebolavirus outbreak in the Democratic Republic of the Congo, the Oxford Vaccine Group (OVG) is working urgently with Oxford’s own Clinical BioManufacturing Facility and the Serum Institute…